Royal Bank of Canada
RNLX

Royal Bank of Canada’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Royal Bank of Canada’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20
Closed – – 7656
2024
Q2 		$0 Sell
20
-44
-69% -$26 ﹤0.01% 7680
2024
Q1 		$0 Hold
64
– – ﹤0.01% 7747
2023
Q4 		$0 Buy
+64
New +$51 ﹤0.01% 7713
2023
Q3 		– Sell
-20,000
Closed -$58K – 7745
2023
Q2 		$58K Buy
+20,000
New +$45.3K ﹤0.01% 5706
2022
Q3 		– Sell
-2,250
Closed -$6K – 7992
2022
Q2 		$6K Buy
2,250
+900
+67% +$4.28K ﹤0.01% 6602
2022
Q1 		$10K Sell
1,350
-400
-23% -$4.24K ﹤0.01% 6957
2021
Q4 		$28K Buy
1,750
+1,050
+150% +$21K ﹤0.01% 6650
2021
Q3 		$14K Buy
700
+667
+2,021% +$17.2K ﹤0.01% 6851
2021
Q2 		$1K Sell
33
-178
-84% -$5.33K ﹤0.01% 7363
2021
Q1 		$5K Buy
+211
New +$5.29K ﹤0.01% 7061

Other funds holding RNLX

PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada's RNLX Position: Q3 2024 in Review

Royal Bank of Canada sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2024, closing a stake of 20 shares.

Royal Bank of Canada first reported a position in RNLX in Q1 2021 and held it in 10 quarters. The position peaked at $58K in Q2 2023. 24 funds tracked by Wall St. Rank hold RNLX as of Q3 2024.

  • Royal Bank of Canada reported no remaining Renalytix plc American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 20 Renalytix plc American Depositary Shares shares in Q3 2024.
  • Royal Bank of Canada first reported a position in Renalytix plc American Depositary Shares in Q1 2021 and held it in 10 quarters.
  • Royal Bank of Canada's Renalytix plc American Depositary Shares position peaked at $58K in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.